Nonpharmacological Therapies for Interstitial Lung Disease

[1] Meyer K(2014)Diagnosis and management of interstitial lung disease Transl Respir Med 2 4-1033

[2] Morisset JDB(2016)The unmet educational needs of interstitial lung disease patients: setting the stage for tailored pulmonary rehabilitatio Ann Am Thorac Soc 13 1026-504

[3] Garvey C(2018)Randomised clinical trial of an early palliative care intervention (SUPPORT) for patients with idiopathic pulmonary fibrosis (IPF) and their caregivers: protocol and key design considerations BMJ Open Respir Res 5 e000272-1365

[4] Bourbeau J(2018)Symptom prevalence of patients with fibrotic interstitial lung disease: a systematic literature review BMC Pulm Med 18 78-484

[5] Collard HR(2010)Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology Eur Respir J 35 496-879

[6] Swigris JJ(2016)Symptom-based management of the idiopathic interstitial pneumonia Respirology 21 1357-1386

[7] Lee JS(2013)Role of support measures and palliative care Curr Opin Pulm Med 19 480-619

[8] Lindell K(2013)Interventions to improve symptoms and quality of life of patients with fibrotic interstitial lung disease: a systematic review of the literature Thorax 68 867-210

[9] Nouraie M(2015)An official American Thoracic Society/European Respiratory Society policy statement: enhancing implementation, use, and delivery of pulmonary rehabilitation Am J Respir Crit Care Med 192 1373-101

[10] Klesen MJ(2017)The evidence of benefits of exercise training in interstitial lung disease: a randomised controlled trial Thorax 72 610-398

[1] Meyer K(2014)Diagnosis and management of interstitial lung disease Transl Respir Med 2 4-1033

[2] Morisset JDB(2016)The unmet educational needs of interstitial lung disease patients: setting the stage for tailored pulmonary rehabilitatio Ann Am Thorac Soc 13 1026-504

[3] Garvey C(2018)Randomised clinical trial of an early palliative care intervention (SUPPORT) for patients with idiopathic pulmonary fibrosis (IPF) and their caregivers: protocol and key design considerations BMJ Open Respir Res 5 e000272-1365

[4] Bourbeau J(2018)Symptom prevalence of patients with fibrotic interstitial lung disease: a systematic literature review BMC Pulm Med 18 78-484

[5] Collard HR(2010)Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology Eur Respir J 35 496-879

[6] Swigris JJ(2016)Symptom-based management of the idiopathic interstitial pneumonia Respirology 21 1357-1386

[7] Lee JS(2013)Role of support measures and palliative care Curr Opin Pulm Med 19 480-619

[8] Lindell K(2013)Interventions to improve symptoms and quality of life of patients with fibrotic interstitial lung disease: a systematic review of the literature Thorax 68 867-210

[9] Nouraie M(2015)An official American Thoracic Society/European Respiratory Society policy statement: enhancing implementation, use, and delivery of pulmonary rehabilitation Am J Respir Crit Care Med 192 1373-101

[10] Klesen MJ(2017)The evidence of benefits of exercise training in interstitial lung disease: a randomised controlled trial Thorax 72 610-398